Global Biochips Based In-vitro Diagnostics Market Report and Forecast 2024-2032

Global Biochips Based In-vitro Diagnostics Market Outlook

The global biochips based in-vitro diagnostics market is expected to grow at a CAGR of 15.5% during the period 2024-2032. North America, Europe and Asia are expected to be key markets.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Advancements in Biochip Technology and Increasing Research in the Domain

Biochip, a collection of multiple tests on one chip, offers multiplexing capacity to the analysis, enhancing test efficiency. Prominent technologies comprising bio/tissue chips include biosensors, microarrays, and microfluidics-based systems; the most significant, however, is Lab on a Chip (LOC). This is where other technologies are merged with microfluidics, allowing parallelism, multiplexing and ability to manipulate fluidic properties to devise complete bioassay on a biosensor surface. Applications of bio/tissue chips encompass almost every form of in-vitro diagnostics (IVD), including DNA applications (gene expression, cancer diagnosis & treatment, genomics, SNP genotyping, drug discovery, agricultural biotechnology, etc.), lab on chip applications (diagnostics, drug discovery, proteomics, genomics, IVD & POC, high throughput screening, etc.), protein microarray applications (diagnostics, expression profiling, high throughput screening, proteomics, drug discovery, etc.), other array applications (cancer diagnostics, expression profiling, genomics, drug discovery, toxico-genomics, etc.). Such applications are expected to boost the global biochips based in-vitro diagnostics market. Several major players in the IVD industry are engaged in biochips manufacturing and research.

Increasing Research and Development Activity and Growing Number of Applications of Biochips Expected to Boost Market Growth

In terms of demand, the total investment in research and development domain is determined by the platforms that have real world practical applications. New biochip-based technologies have significant potential to challenge or replace some microplate-based methods. Increasing research in the domain and number of products are indicative of cumulative growth. Rising number of key players in the biochip industry and growing number of applications of bio/tissue chips indicate a promising market during the forecast period. Biochips such as uTAS devices for diagnosis and implantable devices such as trauma monitoring for efficient therapeutics are some real-world applications driving the in-vitro diagnostics domain.  Such applications are expected to boost the global biochips based in-vitro diagnostics market. Researchers from the Universidad Carlos III de Madrid (UC3M), the Universidad Politécnica de Madrid (UPM) and other entities designed a novel biochip that simplified the process of manufacturing in-vitro skin in the laboratory and other complex multi-layer tissues. Human skin modelled with the help of this device could be employed in medicine and cosmetic testing, which would help decrease the cost of these preclinical trials.

Biochip applications range from human diagnostics to food analysis. For example, the PapilloCheck® test system spots various types of virus that cause cervical cancer (HPV). The ParoCheck® DNA chip recognizes a distinctive range of bacteria that cause gingivitis and periodontitis. CarnoCheck® DNA chip allows the detection of up to eight animal species in food items and animal feeds. The CytoInspec^TM test system recognizes contamination with mycoplasmas in biological materials at the species level and was developed for quality assurance in the biopharmaceutical industry.

Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By application, the market is segmented into:

• DNA Applications
• Lab-on-chip Applications
• Protein Micro-array Applications
• Others

By end use, the market is classified into:

• Hospitals and Clinics
• Research Institutions
• Diagnostic Centres
• Others

By region, the market is divided into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the global biochips based in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Greiner Bio One International GmbH
• SCHOTT AG
• Randox Laboratories Ltd.
• PerkinElmer, Inc. 
• HORIBA, Ltd. 
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report